In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin;Metisiline dirençli staphylococcus aureus izolatlarinin vankomisin, teikoplanin, linezolid ve daptomisine in vitro duyarliliklari

Mikrobiyoloji Bulteni

Volumn 45, Issue 3, 2011, Pages 512-518

  Çelikbilek, Nevreste ^a   Özdem, Birsen ^a   Gürelik, Feryal Ç ^a   Güvenman, Selda ^a   Güner, H Rahmet ^a   Açikgöz, Ziya Cibali ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Daptomycin; Linezolide; Methicillin resistant Staphylococcus aureus; Susceptibility; Teicoplanin; Vancomycin

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; DAPTOMYCIN; LINEZOLID; OXAZOLIDINONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; TEICOPLANIN; VANCOMYCIN;

EID: 80052500025     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. st century: minimum inhibitory concentration creep, bacterial/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006; 42(Suppl): 13-24.
2. Cepeda J, Hayman S, Whitehouse T, et al. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in intensive care unit. J Antimicrob Chemother 2003; 52(3): 533-4. (Pubitemid 37120749)
3. Küçükbayrak A, Özdemir D. Iki yeni protein sentez inhibitörü: Linezolid ve streptograminler (Kinopristin/Dalfoprustin). Infeksiyon Derg 2006; 20(2): 145-51.
4. Hancock RE. Mechanism of action of newer antibiotics for gram-positive pathogens. Lancet Infect Dis 2005; 5(4): 209-18. (Pubitemid 40410066)
5. Garcia MS, Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistance Staphylococcus aureus in intensive care unit. JAMA 2010; 303(22): 2260-4.
6. Sader HS, Watters AA, Fritsche TR, Jones RN. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). BMC Infect Dis 2007; 7: 29.
7. th ed. CLSI, Wayne, PA.
8. Sakoulas G, Moellering RC. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008; 46 (Suppl 5): 360-7.
9. th Informational Supplement M100-S20, 2010. CLSI, Wayne, PA.
10. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40(1): 135-6. (Pubitemid 27341646)
11. Howden PB, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate strains: resistance mechanisms, laboratory detection and clinical implications. Clin Microbiol Rev 2010; 23(1): 99-139.
12. Kurt Azalp Ö, Timurkaynak F, Kurşun E, Togan T, Arslan H. Hastane infeksiyonlannda izole edilen stafilokok suşlarinda vankomisin ve taykoplanin minimal inhibitör konsantrasyonlarinin 7 yil öncesi ile karçilaştirilmasi. Klimik Dergisi 2005; 18(Özel Sayi 1): 226.
13. Kurutepe S, Sürücüoǧiu S, Gazi H, Teker A, Özbakkaloǧlu B. Metisiline dirençli ve duyarli Staphylococcus aureus suşlarinin antibiyotiklere direnç oranlari. Infeksiyon Derg 2007; 21 (4): 187-91.
14. Ekşi F, Gayyurhan ED, Bayram A. Gaziantep Üniversitesi Hastanesinde izole edilen Staphylococcus aureus suşlarinin antimikrobiyal duyarliliklan. ANKEM 2008; 22(4): 203-8.
15. Sancak B, Ercis S, Menemenlioǧlu D, Çolakoǧlu S, Hasçelik G. Methicillin-resistant Staphylococcus aureus heterogeneous resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005; 56(3): 519-23. (Pubitemid 41264130)
16. Dizbay M, Sipahi AB, Günal Ö ve ark. Metisiline dirençli Staphylococcus aureus izolatlarinda linezolid duyar-liliǧinin saptanmasi ve glikopeptid direncinin arajtinlmasi. Klimik Dergisi 2005; 18 (Özel Sayi 1): 230.
17. Aktaş, E, Mengeloǧlu FZ, Külah C, Cömert F. Çeşitli örneklerden izole edilen MRSA suşlarinda vankomisine karşi azalmiş duyarliliǧin araş tirilmasi. Mikrobiyol Bul 2010; 44(2): 339-41.
18. Tigen Tükenmez T, Ergönül Ö, Söyletir G ve ark. Staphylococcus aureus klinik izolatlannda vankomisin MIK deǧerleri daǧilimi. 9. Febril Nötropeni Simpozyumu. 25-28 Şubat 2010, Ankara. Sempozyum Kitabi, s: 173.
19. Efe Ş, Özakin C, Yilmaz E, Akalm H, Gedikoǧlu S. Metisilin dirençli Staphylococcus aureus izolatlannda linezolid duyarliliǧi. Klimik Dergisi 2005; 18(Özel Sayi 1): 239.
20. Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 2006; 50(4): 1581-5.
21. Cui L, Tominaga E, Neoh HM, Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50(3): 1079-82. (Pubitemid 43327815)
22. Bozkurt Yilmaz G, Kutlu H, Arslan A, Memikoǧlu O. Yeni bir antibakteriyel ajan: Daptomisin. Ankara Üniversitesi Tip Fakültesi Mecmuasi 2010; 63(3): 85-8.
23. Öksüz L, Gürler N. Klinik örneklerden izole edilen metisiline dirençli stafilokok suşlannin son yillarda kullanima giren antibiyotiklere in-vitro duyarhhk sonuçlari. ANKEM 2009; 23(2): 71-7.
24. febrilnotropeni.net/pdf/subat/Deniz-Gur.pdf
25. Holmes RL, Jorgensen JH. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob Agents Chemother 2008; 52(2): 757-60. (Pubitemid 351170860)